AzTrials
AzTrials

Symptomatic Musculoskeletal DiseasesPhase 1I-PreventiveNCT02350244

Active Prevention of MSDs (Musculoskeletal Disorders, Upper and Spine Members) in the Context of Computer Screen Work

A Phase 1 study testing Computer program in people with Symptomatic Musculoskeletal Diseases and Latent Musculoskeletal Diseases, run by University Hospital, Clermont-Ferrand at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Evaluate the benefit of an intervention by a computer program comprising active breaks, in the form of a personalized self-program on functional impairment and / or pain, among employees with latent or symptomatic upper extremity MSDs and spine (+/- eyestrain) in connection with the computer work environment. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
What is being tested?
Computer program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteFrance
Study dates
Jun 2014to Jan 2015
Phase
Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • - To carry out a professional activity.
  • To be involved in a computer work for at least 5 hours a day.
  • To be between 18 and 65 years.

Who cannot join

  • - To be in sick leave.
  • Rheumatic and neurological diseases which needed treatment.
  • Workstations which have been recently changed.
  • A behavioral and/or comprehension trouble

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU de Clermont-Ferrand

    Clermont-Ferrand, 63003

Other trials in France

About this study

Evaluate the benefit of an intervention by a computer program comprising active breaks, in the form of a personalized self-program on functional impairment and / or pain, among employees with latent or symptomatic upper extremity MSDs and spine (+/- eyestrain) in connection with the computer work environment.

Read the detailed description

The benefit of the intervention will be assessed among four groups of subjects: symptomatic and asymptomatic subjects randomized in control or experimental group.

Subjects of the experimental group will have to follow an intervention for one month, consisting in active breaks from computer work. Control group patients had no intervention.

Symptoms of MSD will be assessed via questionnaire before and after intervention, in all groups.

Being tested
Computer program
Keywords
musculoskeletal diseases, eyestrain, occupational diseases, computer work, muscle stretching exercise, computer software application, MSDs
Medical subject headings
Musculoskeletal Diseases, Asthenopia, Occupational Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Computer programBehavioural

    Intervention consists in a computer program suggesting workers to take active breaks at given times of their working day, during one month.

Study groups in NCT02350244
Study groupRoleWhat they receive
Experimental groupExperimentalSubjects of the experimental group will have to follow an intervention for one month, consisting in active breaks from computer work
Receives: Behavioral: Computer program
Control groupOtherControl group patients had no intervention
Receives: Behavioral: Computer program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Nordic style questionnaire score

    Measured: at 1 month

Secondary outcomes (5)
  1. Evolution of " Nordic style " and eyestrain questionnaires

    Measured: at 1 month

  2. Evolution of global psychological status (HAD)

    Measured: at 1 month

  3. Evolution of psychosocial work characteristics (VAS stress and satisfaction at work)

    Measured: at 1 month

  4. Occurrence sick leave and frequency of work trips during the study.

    Measured: at 1 month

  5. Adherence to the self-program

    Measured: at 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jan 2015 (estimated)
  2. Study startJun 2014
  3. Primary completionNov 2014
  4. Study completionJan 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1
Allocation
Randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
200 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02350244
Sponsor's protocol ID
CHU-0219
Acronym
I-Preventive
Status last verified
Jan 2015
First submitted
13 Jan 2015
Last updated
29 Jan 2015
Results posted
No

Publications

  • Lanhers C, Pereira B, Garde G, Maublant C, Dutheil F, Coudeyre E. Evaluation of 'I-Preventive': a digital preventive tool for musculoskeletal disorders in computer workers-a pilot cluster randomised trial. BMJ Open. 2016 Sep 22;6(9):e011304. doi: 10.1136/bmjopen-2016-011304.

    PubMed 27660316

Questions about this trial

What is this clinical trial studying?

A Phase 1 study testing Computer program in people with Symptomatic Musculoskeletal Diseases and Latent Musculoskeletal Diseases, run by University Hospital, Clermont-Ferrand at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Jan 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Nordic style questionnaire score (time frame: at 1 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02350244, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jan 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in